weight loss with glp-1 agonists GLP-1R for Part 2 of a 3-Part
Description
Grutzik, R
Can J Biochem 49(8):867872 Brown J, Dryburgh J, Ross S, Dupre J (1975) Identification and actions of gastric inhibitory polypeptide
10.1016/j.jacc.2021.12.011 31 HermansenK.BkdalT
A high concentration of KCl (60 mM) was administered to depolarize the cells, including the sympathetic nerve endings, and an increase in the NE concentration on the mucosal side was confirmed (Fig
Action of glucagon-like peptide-1 (GLP-1) in humans.
[DOI] [PubMed] [Google Scholar] 20.Pfeffer M.A., Claggett B., Diaz R., Dickstein K., Gerstein H.C., Kber L.V., Lawson F.C., Ping L., Wei X., Lewis E.F., et al
